Thursday, December 4, 2008 - 6:31PM EST

General Interest Articles

21. Management of hepatic metastasis of gastrointestinal carcinoid tumors.

Author
Landry CS; Scoggins CR; McMasters KM; Martin RC 2nd;
Institution
Department of Surgery, Division of Surgical Oncology, James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, Kentucky 40202, USA.
Journal
J Surg Oncol. 2008 Mar 1;97(3):253-8.
Abstract URL
Click here to view abstract

22. Acromegaly caused by ectopic growth hormone: a rare manifestation of a bronchial carcinoid.

Author
Biswal S; Srinivasan B; Dutta P; Ranjan P; Vaiphei K; Singh RS; Thingnam SS;
Institution
Department of Cardiothoracic and Vascular Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Journal
Ann Thorac Surg. 2008 Jan;85(1):330-2.
Abstract URL
Click here to view abstract

23. Initial bronchoscopic treatment for patients with intraluminal bronchial carcinoids.

Author
Brokx HA; Risse EK; Paul MA; Grunberg K; Golding RP; Kunst PW; Eerenberg JP; van Mourik JC; Postmus PE; Mooi WJ; Sutedja TG;
Institution
Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands.
Journal
J Thorac Cardiovasc Surg. 2007 Apr;133(4):973-8.
Abstract URL
Click here to view abstract

24. Molecular targeted therapy for carcinoid and islet-cell carcinoma.

Author
Yao JC;
Institution
Department of Gastrointestinal Medical Oncology, Unit 426, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
Journal
Best Pract Res Clin Endocrinol Metab. 2007 Mar;21(1):163-72.
Abstract URL
Click here to view abstract

25. Carcinoid tumours in the gastrointestinal tract--a population-based study from Western Norway.

Author
Helland SK; Prosch AM; Viste A;
Institution
Department of Surgical Sciences, University of Bergen.
Journal
Scand J Surg. 2006;95(3):158-61.
Abstract URL
Click here to view abstract

26. Decreased immunoreactivity of CD99 is an independent predictor of regional lymph node metastases in pulmonary carcinoid tumors.

Author
Pelosi G; Leon ME; Veronesi G; Spaggiari L; Pasini F; Viale G;
Institution
Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy. giuseppe.pelosi@ieo.it
Journal
J Thorac Oncol. 2006 Jun;1(5):468-77.
Abstract URL
Click here to view abstract

27. Carcinoid heart disease in patients without hepatic metastases.

Author
Bernheim AM; Connolly HM; Pellikka PA;
Institution
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA.
Journal
Am J Cardiol. 2007 Jan 15;99(2):292-4. Epub 2006 Nov 27.
Abstract URL
Click here to view abstract

28. Prognosis in lung carcinoid tumours. Is there a difference between atypical and typical carcinoids with and without metastasis?

Author
Sands TJ; Soomro IN; Chaudry ZR; Ronan J;
Institution
Journal
Histopathology. 2006 Dec;49(6):653-4.

29. Carcinoid of the rectum risk stratification (CaRRS): a strategy for preoperative outcome assessment.

Author
Fahy BN; Tang LH; Klimstra D; Wong WD; Guillem JG; Paty PB; Temple LK; Shia J; Weiser MR;
Institution
Department of Surgery, Division of Colorectal Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.
Journal
Ann Surg Oncol. 2007 Feb;14(2):396-404. Epub 2006 Nov 9.
Abstract URL
Click here to view abstract

30. Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type.

Author
Borch, Kurt; Ahren, Bo; Ahlman, Hakan; Falkmer, Sture; Granerus, Goran; Grimelius, Lars;
Institution
Department of Surgery, University Hospital of Linkoping, Linkoping, Sweden. Kurk.Borch@ibk.liu.se
Journal
Ann Surg 2005 Jul;242(1):64-73.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5